50 mg/mL Virazole

DRUG2 trials

Sponsors

Bausch Health Americas, Inc.

Conditions

COVID19

Phase 1

Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19_#2

WithdrawnNCT04356677

Bausch Health Americas, Inc.COVID19

Start: 2021-05-31End: 2021-08-31Updated: 2025-09-16

Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19

CompletedNCT04551768

Bausch Health Americas, Inc.COVID19

Start: 2021-02-10End: 2021-08-17Updated: 2021-08-26